Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements […]
Mission Bio Develops Single-Cell Solution to Address Challenges in Genome Editing
Mission Bio, the single-cell DNA and multi-omics company, announced today the Tapestri® Genome Editing Solution, […]
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell […]
Sequanta and Mission Bio Announce Strategic Partnership
Sequanta Technologies Co., Ltd. and Mission Bio are pleased to announce that they have entered […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more